Stocks

If you are having problems accessing, please clear your browser data (cache and cookies) for the last 4 weeks and try again. If you are still having problems, please contact us at +47 21 555 888.

Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Name	Symbol	Analysis date	Close	+/- %
AcouSort	4SA	Apr 25, 2025	0.27	+1.13
ACRES Commercial Realty D Pref	R9L0	Apr 25, 2025	17.60	-5.38
Acrinova A	9M0	Apr 25, 2025	0.97	+10.86
ACROUD	7NG	Apr 25, 2025	0.00	+200.00
Acrow Formwork and Construction Services Limited	59Y	Apr 25, 2025	0.59	+1.72
Acrux Ltd	FJY	Apr 25, 2025	0.01	+25.00
ACS A.DE C.ADR 1/5/EO-,50	OCI	Apr 25, 2025	10.60	+1.92
ACS Actividades de Construccion y Servicios SA	OCI1	Apr 25, 2025	53.45	+4.50
Actia Group	AG9	Apr 25, 2025	2.90	+6.23
Actic Group	8XA	Apr 25, 2025	1.52	+41.20
Actinium Pharmaceuticals, Inc. (Delaware)	7AY1	Apr 25, 2025	1.10	+1.20
Actinogen Medical Limited	3AC	Apr 25, 2025	0.01	0.00
Active Biotech	BTPC	Apr 25, 2025	0.01	-3.51
ActiveOps Plc	95D	Apr 25, 2025	1.16	+21.47
Activia Properties Ordinary Shares (Japan)	7ZY	Apr 25, 2025	1 980.00	0.00
Acuity Brands, Inc.	AQ8	Apr 25, 2025	214.00	+5.94
ACUITY RM LS,001 POST REO	BJZ0	Apr 25, 2025	0.02	0.00
Acushnet Holdings Corp.	163	Apr 25, 2025	54.50	+4.81
Acuvi AB	OQ2	Apr 25, 2025	1.24	+4.22
Ad Pepper Media Intl Nv	APM	Apr 25, 2025	2.66	+9.92
Adagene Inc. - ADS, each representing 1.25 ordinary shares	978	Apr 25, 2025	1.21	-11.03
Adairs Limited	1FQ	Apr 25, 2025	1.18	+3.51
Adamas Finance Asia Limited	1CP0	Apr 25, 2025	0.01	0.00
Adamera Minerals	AQM0	Apr 25, 2025	0.02	0.00
Adaptimmune Therapeutics plc - American Depositary Shares	473A	Apr 25, 2025	0.22	+26.01
Adaptive Biotechnologies Corporation	1HM	Apr 25, 2025	6.86	+4.76
ADARO EN.IND.ADR/50 RP100	A640	Apr 25, 2025	4.52	+3.67
Adaro Energy Tbk, PT	A64	Apr 25, 2025	0.09	+6.36
Adastra Holdings	D2E0	Apr 25, 2025	0.18	+0.55
Adastria Co.Ltd.	1E0	Apr 25, 2025	17.30	+3.59

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.